Three BRICS Launch Generic Challenge For Vertex’s Landmark CF Therapy

Representatives Call Out Originator’s ‘Repeated Strategy Of Stubborn Negotiation’

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.